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Polyadenylation and splicing of heterogeneous nuclear RNA, two crucial steps in mRNA processing, are 
apparently enzymically mediated processes. This contribution summarizes the properties and the presumed 
functions of the known poly(A) catabolic enzymes (endoribonuclease IV and V, 2: 3 ’ -exoribonuclease) as 
well as those of the pyrimidine-specific endoribonucleases associated with snRNP-hnRNP complexes 
(endoribonuclease VII, acidic pZ 4.1 endoribonuclease and poly(U)-specific Ul snRNP-nuclease). 
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1. INTRODUCTION 
Internal membranes partition the eucaryotic 
cells into functionally distinct compartments. In 
eucaryotes the DNA is sequestered in the nucleus 
which is delimited by the nuclear envelope. This 
double membrane isolates DNA replication, RNA 
transcription and RNA processing from protein 
translation. In procaryotic organisms mRNAs are 
transcribed in most instances from polycistronic 
transcriptional units and are translated as such 
even before the transcription process has been 
completed. In contrast to procaryotic mRNA, the 
primary gene transcript of eucaryotes, which is 
termed heterogeneous nuclear RNA (hnRNA), 
must be modified by a series of posttranscriptional 
processing steps (capping, cleavage, polyadenyla- 
tion, methylation and splicing) before it can leave 
the nucleus through the nuclear pore complex [ 1,2] 
as translationally active mRNA. Such steps pro- 
vide eucaryotes with the opportunity for a regula- 
tion of mRNA synthesis at the level of post- 
transcription [3]. In most mature eucaryotic cell 
types less than 20% of the hnRNA molecules are 
processed to mRNAs [4]. Parallel with the process- 
ing of expressed genes, a reduction of sequence 
complexity of hnRNA to mRNA occurs [5]. The 
processing reactions proceed matrix associated [6] 
and are both structurally [7] and enzymatically 
controlled [8,9]. 
In this review, we provide a brief synopsis of 
those ribonucleases which are presumably involved 
in poly(A) metabolism of mRNA and in some 
events during the overall splicing reaction. 
2. POLY(A) METABOLIC ENZYMES 
Most eucaryotic mRNAs, from sponges [lo] to 
humans, carry a polyadenylic acid sequence 
[poly(A)] of 50-250 AMP residues at the 3 ‘-end 
[l 11. This highly conserved sequence has also been 
detected during the initial stage of synthesis of 
some histone mRNAs [12]. In contrast, the bulk of 
procaryotic mRNAs lack poly(A) tracts (see [8]). 
The chain length of poly(A) tails is determined 
by the interplay between poly(A) anabolic and 
poly(A) catabolic enzymes which is under partial 
control of non-enzymic molecules (see below). 
* To whom correspondence should be addressed 
Poly(A) synthesis is mediated by poly(A) 
polymerase(s) (EC 2.7.7.19) (review [13]) and oc- 
curs at the 3 ‘-OH terminus in pre-mRNA usually 
lo-30 nucleotides downstream from the 
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5 ’ -AAUAAA-3 ’ sequence [14]. A specific en- 
donuclease, perhaps complexed with the poly(A) 
polymerase, has been implicated in 3 ‘-end forma- 
tion [15]. 
2.1. Poly(A)-specific ribonucleases 
It is well established that nuclear poly(A) + 
mRNA or its precursor are not quantitatively 
recovered in the cytoplasm [ 161, indicating that an 
intranuclear turnover of poly(A) occurs. Detailed 
analytical studies revealed that poly(A) shortening 
proceeds by endonucleolytic cleavage [171, during 
which oligo(A) fragments with less than 20 AMP 
residues are released [18]. In 1975 we discovered 
the first poly(A)-degrading nuclease [19] which 
was later purified from chick oviduct to 
homogeneity [20] and termed endoribonuclease IV 
(EC 3.1.26.6). This enzyme (Mr 45000) is highly 
specific for poly(A) [2 11, and displays no influence 
on the integrity of the polyribosomal complex or 
the translational capacity of cell-free protein- 
synthesizing systems. The enzyme forms oligonuc- 
leotides of an average chain length of 10 AMP 
units which are terminated by 3 ‘-OH and 5 ’ -P 
ends. The poly(A)-free part of the mRNA molecule 
remains unaffected. We could detect this enzyme 
in oviduct cells only in the nucleus [21], while some 
evidence has been presented that it is also localized 
in the cytoplasm from rat liver cells [22]. Similarly 
to the poly(A) polymerase, the activity of endori- 
bonuclease IV is also under the control of actin 
and tubulin, if tested in vitro [23] and it is perhaps 
modulated by a posttranslational phosphorylation 
process [24]. A further peculiar property of the 
endoribonuclease IV, which could be of potential 
physiological importance, is its high affinity to 
bind to poly(A) polymerase [20,25]. 
The second endonuclease, termed endoribonuc- 
lease V (EC 3.1.27.8), which we have detected in 
calf thymus and purified to homogeneity (table 1) 
cleaves specifically single-stranded poly(A) and 
poly(U); none of the other single- as well as 
double-stranded synthetic polyribo- and polyde- 
oxyribonucleotides tested were degraded [26]. In 
contrast to endoribonuclease IV, endoribonuclease 
V produces 3 ’ -AMP as end product. The enzyme 
consists of one polypeptide chain with an Mr of 
52300; its isoelectric point was determined to be 
6.3. 
In 1967, authors in [27] described an ex- 
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oribonuclease with a high specificity for poly(A). 
We discovered a similar or identical poly(A)- 
specific exoribonuclease, termed 2’ ,3’-exoribo- 
nuclease (EC 3.1.13.4), first in crude extracts from 
L5178y cells [28] and later in calf thymus from 
which we purified the enzyme to homogeneity [29]. 
The exoribonuclease, which is composed of two 
subunits with Mr 58 000 and 3 1000, cleaves specifi- 
cally poly(A) in the single- or double-stranded form 
[poly(A) - poly(U)] under formation of 5 ’ -AMP 
(3’-exonucleolytic activity). The exoribonuclease 
does not disintegrate polyribosomes isolated from 
quail oviduct. Interesting was the finding [30] that 
this enzyme degrades not only oligoadenylates with 
3’-5’-linkages but also the 2’-5 ‘-linked oli- 
gomers (2 ’ -exonucleolytic activity) which are syn- 
thesized in interferon-treated cells [3 1,321. 
2.2. Potential regulatory function 
It has been shown by a series of studies that the 
poly(A)-metabolizing enzymes respond to altered 
physiological conditions and neoplasia. Pertinent 
data on the changes of poly(A) polymerase activity 
have been excellently reviewed [ 13,331. 
Determinations of the levels of poly(A)- 
metabolizing enzymes, which are present in the 
nucleus of synchronized L5 178~ cells revealed [28] 
that the activity of poly(A) polymerase remains 
essentially constant during the transition from the 
Gi to S phase. However, the extractable poly(A) 
catabolic enzyme activities change parallel with the 
extent of DNA synthesis. Endoribonuclease IV in- 
creases 4-fold during the transition from the Gi to 
S phase, while 2 ’ ,3 ’ -exoribonuclease activity in- 
creases 30-fold. This means that during the S phase 
a change of the balance between poly(A) anabolic 
and poly(A) catabolic enzymes occurs in favour of 
the latter. This result agrees well with the observa- 
tions that during the S phase most of the isolated 
mRNAs which are formed are devoid of poly(A) 
[34]. A similar parallelism between the amount of 
DNA synthesis and the extent of extractable 
poly(A) catabolic enzyme has been observed in 
herpes simplex virus-infected cells [ 10,351. The 
balance between the poly(A) metabolic enzymes 
also changes during the development of the 
organism. Studies with quail oviduct revealed [36] 
that the activity of the extractable poly(A) poly- 
merase remains unchanged uring the post-mature 
period, while the activity of endoribonuclease IV 
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increases l.Zfold and that of the poly(A)-specific 
2 ’ ,3 ’ -exoribonuclease 3-fold during the transition 
from the mature to old stage. Simultaneously per- 
formed analytical studies showed [37] that the size 
of the poly(A) segment of mRNA from old 
oviducts is shorter [average size: poly(A),~] com- 
pared to that measured in mRNA from mature 
oviducts [poly(A)iso]. 
These examples show that the activities of 
poly(A) metabolic enzymes are correlated with the 
physiological state of the organism and hence also 
depend on the developmental stage of the animal. 
The size of the poly(A) segment of mRNA is 
dependent firstly on the balance between the ac- 
tivities of poly(A) anabolic and poly(A) catabolic 
enzymes and secondly on the number of poly(A)- 
associated proteins present per poly(A) tail [37]. 
Previously it was established [38] that en- 
doribonuclease IV does not hydrolyze poly(A) if 
this polymer is ‘protected’ by the associated pro- 
teins; after removal of these proteins, the poly(A) 
segment is rapidly degraded. In contrast, the 
2’,3’-exoribonuclease destroys the poly(A) seg- 
ment independently of the presence of poly(A)- 
associated proteins. 
3. RNP-ASSOCIATED RIBONUCLEASES 
The splicing process occurs in the nucleus and 
usually follows poly(A) addition. Compared to the 
polyadenylation process, which is completed 
within a few minutes [39], splicing of hnRNA is 
slow and requires approx. 20 min [40]. The splic- 
ing reaction is apparently enzymatically controlled 
[9] and presumably guided by small nuclear RNPs 
(snRNP) [41] and perhaps by the 3’-poly(A) se- 
quence of mRNA [42]. 
3.1. Poly(A)-modulated endoribonuclease VII 
and acidic pI 4. I endoribonuclease 
Recently we succeeded in the isolation and 
purification of a novel pyrimidine-specific 
3 ’ -endoribonuclease (Mr 74000) from calf thymus 
that was termed endoribonuclease VII [43]. The 
enzyme cleaves specifically poly(U) and poly(C) 
while other single-stranded homopolyribo- as well 
as polydeoxyribonucleotides are not degraded; 
poly(A,C) is hydrolyzed to a smaller extent, while 
poly(U) - poly(A) is not degraded at all. During 
hydrolysis, oligo(U)i2 fragments with 3 ‘-OH and 
5 ’ -P termini are formed. The enzyme has a pH op- 
timum of 7.2, an isoelectric point at pH 8.5 and re- 
quires neither monovalent nor divalent cations. 
The enzyme was found to be bound to nuclear 45 S 
particles which are composed of RNA and 10 ma- 
jor proteins; one of these proteins (P74) is the en- 
zyme itself. The most prominent property of the 
enzyme is that its poly(U)-degrading activity could 
be modulated by poly(A). Poly(A)ss stimulates the 
hydrolysis of poly(U) by the enzyme by more than 
100% within a limited concentration range; at a 
molar ratio (based on phosphate content) of ap- 
prox. 1 [poly(A)] : 10 [poly(U)] maximal stimula- 
tion of the enzyme activity was achieved; at lower 
ratios , 1: 2 or 1: 1, the hydrolysis of poly(U) was 
inhibited by 52 or 87070, respectively. Oligo(A)d 
fragments were found to have only a little 
modulating effect on the enzyme activity. On the 
other hand, poly(G) and poly(dA) strongly in- 
hibited endoribonuclease VII. Another remarkable 
feature of the enzyme is its high affinity for 
poly(A) and poly(U); no other homo- or hetero- 
polymeric nucleic acids were found to bind to the 
enzyme. Moreover, an RNA fragment that was 
found to be tightly bound to the enzyme was 
shown to be oligo(U) (unpublished). 
During the final purification of en- 
doribonuclease VII by preparative isoelectric 
focusing, a second endoribonuclease, called ~14.1 
acidic endonuclease, was separated from en- 
doribonuclease VII (~1 8.5 [43]). The p1 4.1 en- 
doribonuclease was found to be associated with 
12 S particles [44] that can be characterized as 
snRNPs by the following criteria. Firstly, by a 
sedimentation coefficient of 12 S; secondly, by 
electrophoresis in SDS-polyacrylamide gels as 
shown in fig. 1 (12 S particles containing the ~14.1 
acidic endoribonuclease show a protein pattern 
which is very similar to that of immunoaffinity 
purified snRNPs [45]); thirdly, by the fact that the 
purification procedure of these particles is closely 
related to that for snRNPs described in [46]; and 
fourthly, by their antigenicity to Sm antibodies as 
checked by counterimmunoelectrophoresis (fig.2). 
The latter finding is in good agreement with the 
results obtained by SDS gel electrophoresis how- 
ing the potential Sm antigens D, E and F [47] to be 
present in the 12 S particles (fig.1). In addition to 
these polypeptides some minor protein bands (A, 
Al, A2, A3, B, C) were found, which could be par- 
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Fig. 1. Polyacrylamide gel electrophoresis of the pZ 4.1 
acidic endoribonuclease-containing 12 S particle and of 
U snRNP. Electrophoresis was performed in SDS- 
polyacrylamide gels (10% separation gel, 6% spacer 
gel). (A) 12 S particle containing the pZ 4.1 acidic 
endoribonuclease, (B) U snRNP purified by 
immunoaffinity chromatography. The following 
proteins were used as standards: (1) bovine serum 
albumin (ZkZ, 68000), (2) egg white albumin (MI 43000), 
(3) chymotrypsinogen A (k& 25 000), (4) trypsin inhibitor 
from soybean (ikfr 21500), (5) ribonuclease A (Mr 13 700) 
and (6) cytochrome c (kfr 12500). BPB, bromophenol 
blue. Protein bands are indicated by capital letters. 
tially adsorbed to an anti-RNP column (A, Al, 
A2). This column was used for isolation of the 
poly(U)-specific Ul snRNP-nuclease (see below). 
In contrast to endoribonuclease VII, the pyrimi- 
dine-specific acidic pl 4.1 endoribonuclease re- 
quires Mg ‘+ for optimal activity and is not 
modulated by polyadenylate. 
3.2. Poly(U)-specific Ul snRNP-nuclease 
Guided by the assumption that Ul snRNA is 
essential for the splicing process we searched for 
nuclease activities associated with Ul snRNP par- 
ticles. Previous reports have indicated the presence 
of poly(A) polymerase [48], a non-specific en- 
doribonuclease [49] and an endoribonuclease 
A 
B 
Fig.2. Counterimmunoelectrophoresis. SnRNPs ob- 
tained by DEAE-cellulose chromatography (100 mM 
NaCl eluate fraction [43]) were analyzed. Lane a, anti- 
Sm; lane b, control serum; lane c, anti-RNP. A, antigen; 
B, antibody. The electrophoresis was performed as in 
WI. 
specific for double-stranded RNA [50] in the 
hnRNP complex. By chromatography on lupus 
erythematosus antibody affinity columns we suc- 
ceeded in identifying a poly(U)-specific en- 
doribonuclease [45]. In SDS-polyacrylamide gels 
the RNP preparation obtained showed a protein 
pattern typical for snRNP; 4 major polypeptides 
(MI 42000, 13500, 11500, 10800) and two minor 
polypeptides (j% 29000,260OO) could be identified 
(fig.lB). Moreover, the particles had the 
characteristic sedimentation coefficient of 12 S. 
Because the antibody contained a high titer of anti- 
Ul snRNP the isolated snRNP should represent 
primarily U 1 snRNPs . The U 1 snRNP-nuclease re- 
quires Mg2+ for optimal activity, has a pH op- 
timum of 6.2 and degrades specifically poly(U) 
under formation of (U)6- 12 oligomers with 3 ’ -OH 
and 5 ’ -P termini. 
3.3. Hypothetical function 
Although the physiological function of en- 
doribonuclease VII, pI 4.1 acidic endoribonuclease 
and poly(U)-specific Ul snRNP-nuclease is not yet 
known, from their presence in RNP particles and 
their characteristics it is likely that these enzymes 
could play a functional role in RNA processing. 
Based on its properties, poly(A)-modulated ‘and 
oligo(U)-recognizing endoribonuclease VII might 
be a 3 ‘-processing enzyme removing the oligo(U) 
sequences from RNA polymerase III transcripts, 
such as 5 S RNA precursors [51] and Ro RNAs 
[52]; perhaps this enzyme may recognize the 
28 
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Fig.3. Possible cleavage points of the poly(U)-specific 
Ul snRNP-nuclease within the Ul snRNP particle. 
(-) Part of the Ul snRNA which is protected against 
nuclease attack by proteins. The poly(U)-specific Ul 
snRNP-nuclease could split the Ul snRNA at dot 1 
(Ul dUl*) or dot 2 (the single unmodified uridylate 
residue within the protein unprotected part of the U2 
snRNP particle). 
pyrimidine-rich stretch in the intron loops of 
hnRNA. In addition, all of these reactions could 
be modulated by the poly(A) sequence and 
therefore be controlled by poly(A) anabolic and 
catabolic enzymes. 
As shown in fig.3, in Ul snRNP the greater part 
of the RNA is protected by protein; only a short 
nucleotide sequence at the 5 ‘-terminus (nucleotide 
residues l-l 1) of the Ul snRNA seems to be pro- 
tein free [53]. Because of its complementarity to 
the 3 ’ - and 5 ‘-donor and acceptor splicing sites, 
this nucleotide sequence is thought to comprise the 
recognition site for the hnRNA splicing apparatus 
[54,55]. In particular, all except one of the 
uridylate residues in this small RNA piece are 
modified by methylation or replaced by 
pseudouridines. It is not yet known whether the 
poly(U)-specific nuclease could cleave at 
pseudouridine residues; if so, one possible func- 
tion of this enzyme might be the conversion of Ul 
to Ul* (dot 1 in fig.3). Another uridylate residue 
at which the Ul snRNA might be cleaved by the 
poly(U)-specific nuclease is the eleventh nucleotide 
from the 5’-end (dot 2) which is the only un- 
modified nucleotide that was found to be protein 
unprotected. Because by both reactions the in- 
teraction of the Ul snRNA with the complemen- 
tary splice sites of hnRNA could be prevented, 
poly(U)-specific and Ul snRNP-associated en- 
doribonuclease might be attributed a modulating 
function during splicing. 
4. THE FUTURE 
This review shows the existence of novel 
ribonucleases present in RNP particles. Two dif- 
ferent yet similar enzymes could be identified in 
12 S snRNPs using homopolymeric nucleic acids 
as substrates. The elucidation of the function of 
these enzymes by the use of their natural substrates 
may be a task for the future. 
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